Urolithin C
CAS No. 165393-06-6
Urolithin C( —— )
Catalog No. M29486 CAS No. 165393-06-6
Urolithin C is a gut metabolite of ellagic acid. Urolithin C induces apoptosis in PC12 cells through a mitochondria-mediated pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 51 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 76 | In Stock |
|
| 25MG | 139 | In Stock |
|
| 50MG | 230 | In Stock |
|
| 100MG | 346 | In Stock |
|
| 200MG | 511 | In Stock |
|
| 500MG | 808 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUrolithin C
-
NoteResearch use only, not for human use.
-
Brief DescriptionUrolithin C is a gut metabolite of ellagic acid. Urolithin C induces apoptosis in PC12 cells through a mitochondria-mediated pathway.
-
DescriptionUrolithin C is a gut metabolite of ellagic acid. Urolithin C induces apoptosis in PC12 cells through a mitochondria-mediated pathway.(In Vitro):Urolithin C is a glucose-dependent activator of insulin secretion acting by facilitating L-type Ca2+ channel opening and Ca2+ influx into pancreatic β-cells.Urolithin C enhanced glucose-induced extracellular signal-regulated kinases 1/2 (ERK1/2) activation as shown by higher phosphorylation levels in INS-1 β-cells. Urolithin C stimulates reactive oxygen species (ROS) formation.(In Vivo):In male Wistar rat, the half-life of the terminal part is 11.3 h and the total clearance (CL/F) is 3.41 L/h/kg. The initial volume of distribution (V1/F) is 0.831 L/kg and the steady-state volume of distribution (Vss/F) is 55.6 L/kg after the intraperitoneal administration of Urolithin C (10 mg/kg).
-
In VitroWestern Blot Analysis Cell Line:INS-1 cells Concentration:20 μM, 100 μM Incubation Time:1 hour Result:Enhanced glucose-induced extracellular signal-regulated kinases 1/2 (ERK1/2) activation.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number165393-06-6
-
Formula Weight244.202
-
Molecular FormulaC13H8O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (204.75 mM)
-
SMILESOc1ccc2c(c1)oc(=O)c1cc(O)c(O)cc21
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
3-O-Methylgallic aci...
3,4-Dihydroxy-5-methoxybenzoic acid reduces cell proliferation in Caco-2 cells(IC50 = 24.1 μM) more effectively than anthocyanins and may offer protection against colon cancer after its formation in the gut. 3,4-Dihydroxy-5-methoxybenzoic acid inhibits transcription factors NF-κB, AP-1, STAT-1, and OCT-1 which are known to be activated in colorectal cancer.
-
Imexon
A 2-cyanoaziridine derivative with antitumor activity in some types of cancer.
-
Etalocib
Etalocib is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase.
Cart
sales@molnova.com